Interstitial 252Cf neutron therapy for glioblastoma multiforme.

Area of Science:

• Oncology
• Radiation Oncology
• Neurosurgery

Background:

• Advanced brain tumors often present with significant size, bulk, and surrounding edema.
• Standard treatments may be insufficient for large, complex intracranial malignancies.
• Novel therapeutic combinations are needed to improve outcomes.

Purpose of the Study:

• To evaluate the safety and efficacy of combined Californium-252 (252Cf) brachytherapy and whole brain photon beam therapy.
• To assess treatment tolerance and tumor response in patients with large brain tumors.
• To determine the necessity of individualized treatment strategies for complex cases.

Main Methods:

• Phase I clinical study combining 252Cf brachytherapy with whole brain photon beam therapy (6000 rads over 5-7 weeks).
• Patient selection for early-phase trials.
• CT scan evaluation for tumor size and edema assessment.
• Performance status monitoring.

Main Results:

• All patients tolerated the combined treatment regimen.
• Observed improvement in patient performance status.
• Demonstrated reduction in tumor size via CT scan.
• Highlighted the challenge of large, bulky tumors with significant edema.

Conclusions:

• Combined 252Cf brachytherapy and photon beam therapy is a tolerable option for brain tumors.
• Effective treatment of large, bulky brain tumors with edema necessitates individualized brachytherapy implants and high-dose external beam radiation.
• Further investigation into tailored approaches for complex brain tumors is warranted.